These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1441492)

  • 1. Successful treatment of markedly symptomatic patients with type II diabetes mellitus using high doses of sulfonylurea agents.
    Davidson MB
    West J Med; 1992 Aug; 157(2):199-200. PubMed ID: 1441492
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML; Visser LE; Trienekens PH; Hofman A; van Schaik RH; Stricker BH
    Clin Pharmacol Ther; 2008 Feb; 83(2):288-92. PubMed ID: 17597710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-response relationships of sulfonylureas: will doubling the dose double the response?
    Rambiritch V; Naidoo P; Butkow N
    South Med J; 2007 Nov; 100(11):1132-6. PubMed ID: 17984746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

  • 6. Pareto's law and sulfonylureas.
    Peiris AN; Micklewright M; Gangadharan V
    South Med J; 2007 Nov; 100(11):1072-3. PubMed ID: 17984734
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].
    Farkas K; Jermendy G; Somogyi A
    Orv Hetil; 1997 Nov; 138(48):3031-5. PubMed ID: 9441264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclohexamide. A new oral hypoglycemic agent].
    Villaseñor A; Parra A; López Amor E; Rull JA; Lozano-Castañeda O
    Rev Invest Clin; 1967; 19(2):149-57. PubMed ID: 5317602
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study.
    Herman WH; Dirani RG; Horblyuk R; O'Neill MC; Kravitz B; Heise MA; Bakst A; Freed MI;
    Am J Manag Care; 2005 Apr; 11(4):273-8. PubMed ID: 15839187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of diabetes with low doses of glypizide].
    Lozano-Castañeda O; Schulte J; Gonzálex Barranco J; García Viveros M; Rull JA
    Prensa Med Mex; 1974; 39(7-8):358-61. PubMed ID: 4453534
    [No Abstract]   [Full Text] [Related]  

  • 17. [Minor differences in outcome comparing early vs. later initiation of medicamentous blood glucose control in type 2 diabetic patients].
    Ritzman P
    Praxis (Bern 1994); 1999 Aug; 88(31-32):1289-90. PubMed ID: 10479970
    [No Abstract]   [Full Text] [Related]  

  • 18. [Practical ambulatory therapy for multisystem atrophy and diabetes mellitus].
    Fassbender WJ
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2347-8. PubMed ID: 16231237
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter study with gliquidone in type 2 diabetes mellitus].
    Kreze A; Vozár J; Rázus P; Lacko A; Málek Z; Putz Z
    Vnitr Lek; 1991; 37(9-10):761-7. PubMed ID: 1771808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.